Financial Performance - The company's gross profit margin decreased to 12.71% in 2022 from 22.17% in 2021, and net profit fell to 7.32 million from 81.85 million in the previous year[12]. - The company's operating revenue for 2022 was ¥785,510,490.19, an increase of 8.57% compared to ¥714,367,715.43 in 2021[36]. - The net profit attributable to shareholders decreased by 91.05% to ¥7,323,074.09 from ¥81,845,580.77 in the previous year[36]. - The net cash flow from operating activities was ¥107,460,910.07, down 38.76% from ¥175,482,675.16 in 2021[36]. - The total assets at the end of 2022 reached ¥1,453,410,688.76, representing a 25.14% increase from ¥1,161,422,423.76 in 2021[36]. - The company's basic earnings per share dropped by 91.67% to ¥0.04 from ¥0.48 in 2021[36]. - The net profit after deducting non-recurring gains and losses was ¥7,870,143.58, a decrease of 87.83% compared to ¥64,673,525.36 in 2021[36]. - The total equity attributable to shareholders decreased by 3.27% to ¥798,373,008.67 from ¥825,368,086.79 in 2021[37]. - The company reported a significant decline in quarterly net profit, with the fourth quarter showing a loss of ¥10,556,681.99[39]. - The company recognized government subsidies amounting to ¥16,915,052.95 in 2022, down from ¥19,678,228.05 in 2021[42]. Market Position and Sales - The company sold approximately 199 million chicks in 2022, capturing a market share of about 18%[15]. - The company holds approximately 18% market share in the domestic market for commercial broiler chicks in 2022, positioning itself among the industry leaders[94]. - The average selling price of chicks was 3.19 yuan per chick, a decrease of 0.23 yuan per chick compared to the previous year[72]. - The company sold 198.69 million chicks, with main chicken product revenue accounting for 85.07% of total revenue[72]. - Direct customer sales increased by 13.28% to ¥530,957,198.81, making up 67.59% of total sales[113]. Production and Operational Efficiency - The company aims to enhance management efficiency and optimize talent structure to improve output per unit and drive sustainable development[4]. - The company plans to enhance its core competitiveness through management and technological innovations, aiming for continuous improvement in market share and profitability[18]. - The company intends to implement a standardized operating model of "centralized breeding and decentralized incubation" to reduce expansion costs and diversify its product offerings[18]. - The company has established four high-standard ecological breeding bases and five hatcheries, with a feed processing plant capable of producing 200,000 tons of chicken feed annually[57]. - The company employs a "centralized breeding, decentralized hatching" model to enhance biosecurity and product quality, ensuring efficient operations[59]. - The company has implemented modern production facilities, including advanced air filtration systems and state-of-the-art hatching equipment, ensuring standardized and mechanized operations[90]. Research and Development - The company has filed 6 patents and received 2 authorized patents during the reporting period, along with 2 software copyrights and 2 technology achievement registrations[76]. - The company established the Ningxia Egg Chicken Industry Research Institute to enhance independent innovation capabilities and develop advanced industry technologies[77]. - The research and development team consists of 221 members, accounting for 11.87% of the total workforce, focusing on animal husbandry, veterinary medicine, and animal nutrition[107]. - The company is focusing on technology innovation in areas such as disease prevention, nutrition, and animal welfare, with a commitment to establishing a comprehensive research and development institution[160]. - The company has been recognized as one of the first ten national breeding bases for chicken varieties and has achieved biosecurity certifications from relevant agricultural authorities[162]. Biosecurity and Disease Management - The company has maintained a strong biosecurity system, with no major infectious diseases reported since its establishment, ensuring the health of the chicken population[80]. - The company has invested in biosecurity measures, including the construction of isolation zones in large-scale poultry farms to prevent disease spread[80]. - The company has implemented a comprehensive biosecurity management system, including strict personnel and vehicle entry protocols to minimize disease risks[84]. - The company has established a comprehensive disease prevention system and specific immunization programs, effectively controlling the occurrence and spread of avian influenza through a mandatory vaccination system[99]. - The company has developed a series of integrated disease prevention and purification technologies, including the use of sentinel chickens for monitoring avian diseases, which enhances early detection and response capabilities[100]. Strategic Planning and Future Outlook - The company aims for a sustainable annual sales growth of approximately 20% while maintaining stable cash flow and increasing market share[159]. - Future guidance suggests a revenue growth target of 12% for 2023, driven by both organic growth and acquisitions[183]. - The company plans to invest 50,000,000 CNY in technology upgrades to enhance production efficiency by 20% in the next fiscal year[183]. - A merger with a local competitor is expected to be finalized by the end of Q2 2023, which could potentially increase market penetration by 30%[183]. - The company is exploring potential acquisitions to enhance its supply chain efficiency, with a budget of CNY 100 million allocated for this purpose[199]. Corporate Governance and Management - The governance structure includes a shareholder meeting, board of directors, supervisory board, and senior management, ensuring a coordinated and balanced mechanism for efficient operations[172]. - The company maintains independence from its controlling shareholder in terms of business, personnel, assets, and finance, ensuring no unfair related transactions occur[175]. - The company has established a sound internal management system and independent financial accounting system[178]. - The company actively engages in investor communication through various platforms, including online roadshows and performance briefings[169]. - The company has independent bank accounts and does not share accounts with controlling shareholders or other enterprises[178].

证券代码：300967 证券简称：晓鸣股份 宁夏晓鸣农牧股份有限公司 投资者关系活动记录表 编号：2023-001 | 投资者关系活动类别 | ☐特定对象调研 ☐分析师会议 | | --- | --- | | | ☐媒体采访 ☐业绩说明会 | | | ☐新闻发布会 路演活动 | | | ☐现场参观 | | | ☐其他（请文字说明其他活动内容） | | 形式 | ☐现场 网上 ☐电话会议 | | 参与单位名称及人员姓名 | 线上参与公司发行可转债网上路演活动的投资者 | | 时间 | 2023年04月04日 15:00-17:00 | | 地点 | 价值在线（https://www.ir-online.cn） | | | 魏晓明 董事长兼总经理； 杜建峰 副总经理兼董事会秘书； | | | 孙灵芝 财务总监； | | 上市公司接待人员姓名 | 杜国文 华西证券股份有限公司副总裁、晓鸣股份保荐代表人； | | | 尹玉堂 华西证券股份有限公司消费行业组高级副总裁、晓鸣股 | | 1. | 份保荐代表人。 贵司产品在国内市场占有率为多少？如何进一步扩大市率？ | | | 答:尊敬的投资者您好！公司目前是中国规模 ...

Company Overview - Ningxia Xiaoming Agricultural and Animal Husbandry Co., Ltd. is a technology-driven egg breeding company located in Ningxia, which successfully went public on April 13, 2021, becoming the first listed company in China's egg industry [1] - The company focuses on breeding, seed production, and the rearing of commercial layer chickens, providing hatchlings to small and large-scale farms [1] Financial Performance - In the first half of the year, the company achieved a revenue of 354 million CNY, representing a year-on-year growth of 26.12% [1] - The net profit attributable to shareholders reached 51.95 million CNY, with a year-on-year increase of 61.23% [2] - The company has maintained an average annual capacity growth rate of 20% over the years, with further capacity release during the reporting period [2] Market Expansion - The company is expanding its market presence with new hatchery and breeding facilities in Changde, Hunan, with an investment of 150 million CNY, ensuring supply in the southern market [2] - In June, the company completed the introduction of 50,006 sets of breeding chickens from the U.S., accounting for 42.94% of the national import volume of breeding chickens in the first half of the year [2] Industry Context - The egg industry experienced overall losses in 2020, primarily at the commercial chicken level, while the breeding segment remained profitable [3] - The egg-laying cycle is approximately 1.5 years, leading to less volatility compared to the pig and broiler chicken industries [2][3] Strategic Insights - The company aims to maintain profitability through brand and quality effects, increasing market share, and focusing on large-scale direct sales to customers [4] - The establishment of a breeding center in Hunan is strategically significant for promoting popular egg-laying breeds in southern and southwestern markets [4] Challenges and Resilience - The company has adopted a centralized breeding and decentralized hatching model, which mitigates the impact of disasters on production [4] - Transportation challenges due to disasters have been managed effectively, leveraging government policies for smooth logistics [4]

编号：【2021】第 003 号 证券代码：300967 证券简称：晓鸣股份 宁夏晓鸣农牧股份有限公司 投资者关系活动记录表 | --- | --- | --- | |------------------------------|-------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | | | | | √特定对象调研 | □分析师会议 | | 投资者关系活 | □媒体采访 | □业绩说明会 | | 动类别 | □新闻发布会 | □路演活动 | | | √现场参观 | □其他 | | 参与单位名称 及人员姓名 | 参会人员：海通 ...

编号：【2021】第 005 号 证券代码：300967 证券简称：晓鸣股份 宁夏晓鸣农牧股份有限公司 投资者关系活动记录表 | --- | --- | --- | |------------------------------|--------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | | | | | 特定对象调研 | □分析师会议 | | 投资者关系活 | □媒体采访 | 业绩说明会 | | 动类别 | □新闻发布会 | 路演活动 | | | 现场参观 | □其他 | | 参与单位名称 及人员姓名 | 天风证券 保险 ...

Financial Performance - The company's revenue for Q3 2022 was ¥180,780,455.62, an increase of 0.66% year-over-year, while the year-to-date revenue reached ¥562,718,292.59, up by 5.40%[5] - The net profit attributable to shareholders for Q3 2022 was a loss of ¥3,343,807.00, a decrease of 113.31% compared to the same period last year, with a year-to-date net profit of ¥17,879,756.08, down by 76.80%[5] - The basic and diluted earnings per share for Q3 2022 were both -¥0.018, reflecting a decline of 113.43% year-over-year, while the year-to-date earnings per share were ¥0.095, down by 79.48%[5] - Total operating revenue for the third quarter of 2022 was CNY 562,718,292.59, an increase from CNY 533,867,246.49 in the same period last year, representing a growth of approximately 5.3%[22] - The company's net profit margin for the third quarter of 2022 was approximately 0.7%, compared to a higher margin in the previous year due to increased costs[22] - The net profit for Q3 2022 was CNY 17,879,756.08, a decrease from CNY 77,066,743.44 in the same period last year, representing a decline of approximately 76.8%[23] - Operating profit for Q3 2022 was CNY 8,120,648.05, compared to CNY 64,838,301.43 in Q3 2021, indicating a significant drop of about 87.5%[23] Assets and Liabilities - The total assets as of September 30, 2022, were ¥1,382,104,244.40, representing a 19.00% increase from the end of the previous year[5] - Current assets decreased to CNY 184,955,538.41 from CNY 292,998,439.08, a decline of approximately 36.9%[20] - Non-current assets increased to CNY 1,197,148,705.99 from CNY 868,423,984.68, showing a growth of about 37.8%[20] - The total liabilities increased to CNY 573,899,991.33 from CNY 336,054,336.97, representing a rise of approximately 70.7%[20] - The company's equity attributable to shareholders decreased to CNY 808,204,253.07 from CNY 825,368,086.79, a decline of approximately 2.1%[21] Cash Flow - Cash flow from operating activities for the year-to-date was ¥83,586,554.13, a decrease of 36.75% compared to the previous year[13] - Cash flow from operating activities for the current period was CNY 83,586,554.13, down from CNY 132,155,681.82 in the previous year, a decrease of approximately 36.7%[24] - Cash flow from investing activities showed a net outflow of CNY 368,787,546.17, compared to a net outflow of CNY 104,705,825.94 in the previous year, indicating a significant increase in investment expenditures[25] - Cash flow from financing activities resulted in a net inflow of CNY 169,738,835.52, compared to a net inflow of CNY 138,541,105.29 in the same period last year, representing an increase of approximately 22.5%[25] - The ending cash and cash equivalents balance was CNY 55,993,346.58, a decrease from CNY 209,524,624.18 at the end of the previous year, indicating a decline of about 73.2%[25] Investments and Expenses - The company reported a significant increase in construction in progress, which rose by 449.07% to ¥192,001,645.41, primarily due to investments in the Southern Seed Industry Center and the Hongsi Fort Smart Agriculture Demonstration Park[9] - The company's other non-current assets increased by 299.77% to ¥53,692,237.74, attributed to increased prepayments for project construction and equipment[9] - The company reported a research and development expense of CNY 20,048,348.93 for the third quarter, compared to CNY 17,417,064.73 in the previous year, indicating an increase of about 9.4%[22] - The company’s management expenses decreased by 37.52% to ¥15,352,600.78, mainly due to the absence of listing-related expenses and bonuses from the previous year[11] Shareholder Information - The total number of common shareholders at the end of the reporting period is 15,890[14] - The largest shareholder, Wei Xiaoming, holds 42.14% of the shares, totaling 80,160,000 shares[14] - The second-largest shareholder, Chia Tai Investment Co., Ltd., holds 11.87% of the shares, totaling 22,580,000 shares[14] - The total number of shares held by the top ten unrestricted shareholders amounts to 66,000,000 shares[15] - The company has a total of 0 preferred shareholders with voting rights restored[14] - The company has a total of 6.38% of shares held by other investors, totaling 12,134,100 shares[14] Convertible Bonds - The company has received approval from the Shenzhen Stock Exchange for issuing convertible bonds, with the application being accepted on June 1, 2022[16] - The company is in the process of responding to inquiries from the Shenzhen Stock Exchange regarding the issuance of convertible bonds[16] - The company has completed the first round of inquiries and is preparing for the second round of inquiries regarding the convertible bond issuance[16] - The company is committed to timely information disclosure regarding the progress of the convertible bond issuance[17]

Demand and Market Position - The company reported a stable demand for commodity chicks, maintaining an annual demand of approximately 1.1 billion chicks, with a market share of 14.95% in 2021, selling 173 million chicks[9]. - The company’s market share for commodity chicks was 14.95% in 2021, with sales of 173 million chicks[154]. - The company sold 95.56 million commodity chicks, representing a year-on-year increase of 16.53%[51]. - In 2021, the company sold 173.31 million commercial chicks, a year-on-year increase of 20.10%, achieving a market share of 14.95%, up 19.41% from the previous year, with revenue reaching 714.37 million yuan, a growth of 32.29%[86]. Financial Performance - The company's revenue for the reporting period was approximately ¥381.94 million, representing a 7.81% increase compared to ¥354.27 million in the same period last year[34]. - The net profit attributable to shareholders decreased by 59.15% to ¥21.22 million from ¥51.95 million year-on-year[34]. - The net profit after deducting non-recurring gains and losses fell by 78.29% to ¥9.41 million from ¥43.32 million in the previous year[34]. - The net cash flow from operating activities decreased by 25.24% to ¥68.04 million compared to ¥91.00 million in the same period last year[34]. - Basic and diluted earnings per share dropped by 65.98% to ¥0.1132 from ¥0.3327 year-on-year[34]. - The weighted average return on net assets decreased to 2.54% from 7.53% in the previous year, a decline of 4.99%[34]. Operational Challenges - The company faced significant cost increases due to rising prices of corn and soybean meal, which are critical raw materials for feed production, leading to a decrease in gross margin[6]. - The company has experienced fluctuations in gross margin and net profit due to upstream raw material price volatility and the impact of the COVID-19 pandemic, indicating potential risks of performance decline and losses[12]. - The company is heavily reliant on a single foreign supplier, Hy-Line International, for its breeding stock, which poses a risk if supply is disrupted due to disease or other factors[8]. - The poultry industry is facing challenges from avian diseases, which could significantly impact production and sales, as well as consumer demand for poultry products[5]. - The company’s operational costs are expected to rise due to increased investments in disease prevention measures and the need for emergency immunization in response to potential outbreaks[5]. - The company acknowledges the potential adverse effects of macroeconomic fluctuations and rising commodity prices on its operational performance[157]. Strategic Initiatives - The company plans to enhance its core competitiveness through management and technological innovations, aiming for increased market share and profitability[15]. - The company will accelerate the development of its main business by promoting a standardized operating model of "centralized breeding and decentralized incubation" to reduce expansion costs[15]. - The company intends to increase investment in technology research and development to improve various technical levels, including biosecurity and disease prevention[15]. - The company is actively advancing the Hongshibao Smart Agriculture Industrial Demonstration Park project and the Southern Seed Industry Center project, which are expected to enhance production capacity[52]. - The company is constructing a smart agriculture demonstration park in Ningxia and a southern seed center in Hunan[41]. - The company is exploring potential mergers and acquisitions to enhance its product offerings and market reach[190]. Research and Development - The company has established a comprehensive technical and R&D system, including a veterinary center and a livestock center, to support disease control and data analysis[114]. - The company has built a strong technical research and development team, focusing on feed nutrition, disease control, and automated breeding technologies, establishing a competitive advantage in the industry[102]. - The company is collaborating with several research institutions and universities to strengthen its technological support and innovation capabilities[120]. - The company is actively applying for multiple patents related to disease prevention and control in poultry farming, including a detection method for Mycoplasma gallisepticum in large-scale chicken farms[113]. Biosecurity Measures - The company has established a disease prevention system tailored to regional and breed characteristics, which is crucial for minimizing losses from outbreaks[75]. - The company has maintained a strong biosecurity system, with no major animal epidemics reported since its establishment, and is the only enterprise in the egg-laying chicken industry to pass the biosecurity assessment for disease-free zones[97]. - The company employs a "full entry, full exit" biosecurity operation model to effectively prevent disease and pest transmission[95]. - Significant investments have been made in the development of a comprehensive biosecurity manual to guide practices and enhance safety awareness[95]. Social Responsibility and Community Engagement - The company has actively engaged in rural revitalization strategies, aligning agricultural modernization with poverty alleviation efforts[104]. - The company has donated 162,050 chicks worth approximately 71,626.00 CNY to 1,316 low-income households, fulfilling its social responsibility[183]. - The company donated 3,000 medical masks and 3,000 rubber gloves, along with living supplies worth 16,319.54 yuan to support local pandemic prevention efforts[180]. - The company is committed to sustainability initiatives, aiming for a 40% reduction in carbon emissions by 2025[190]. Future Outlook - The company provided a positive outlook for the second half of 2022, projecting a revenue growth of 10% to 12%[190]. - New product launches are expected to contribute an additional 200 million RMB in revenue by the end of the year[191]. - The company is expanding its market presence, targeting a 25% increase in market share in the next fiscal year[190]. - Future guidance includes maintaining a gross margin of 35%, supported by cost control measures and operational efficiencies[200].

Investment and Expansion Plans - The company plans to invest in multiple projects, including the Red Desert Smart Agriculture Industrial Demonstration Park and the Alxa Chicken Breeding Farm, with a focus on enhancing production capacity and economic benefits[11]. - The company plans to continue expanding production capacity and increasing market share as its main operational strategy[66]. - The company signed an investment contract for the Southern Seed Industry Center project in Changde, Hunan, with a planned investment of 150 million RMB, covering an area of 100 acres and establishing two automated incubation production lines[82]. - The company plans to invest 300 million RMB in the Red Silk Fort Smart Agriculture Industrial Demonstration Park project in Wuzhong, Ningxia, which is expected to house 1 million parent stock egg-laying chickens upon completion[82]. - The company has invested in a feed processing plant with an annual output of 200,000 tons in its smart agricultural poverty alleviation industrial park[68]. Financial Performance - The company's operating revenue for 2021 was CNY 714,367,715.43, representing a 32.29% increase compared to CNY 540,018,818.00 in 2020[26]. - The net profit attributable to shareholders for 2021 was CNY 81,845,580.77, a 62.88% increase from CNY 50,248,556.43 in 2020[26]. - The net cash flow from operating activities reached CNY 175,482,675.16, a significant increase of 106.77% compared to CNY 84,866,811.79 in 2020[26]. - The total assets at the end of 2021 were CNY 1,161,422,423.76, reflecting a 32.82% increase from CNY 874,431,397.93 at the end of 2020[26]. - The company achieved operating revenue of 714.37 million yuan, a year-on-year increase of 32.29%[80]. Market and Industry Trends - The poultry industry is experiencing price volatility due to macroeconomic factors and seasonal changes, which could affect the sales prices of products[8]. - The egg production model is shifting towards vertical integration, allowing companies to cover the entire supply chain from breeding to egg production, enhancing operational efficiency[46]. - The cooperative farming model, which connects companies with farmers, is gaining traction, allowing for better control over production quality and stability[48]. - The company anticipates ongoing consolidation in the egg-laying industry, with a trend towards increased market concentration and a shift from small-scale to large-scale farming operations[160]. - The demand for chicken eggs is expected to remain strong, particularly in peak consumption months such as January, February, September, and October[57]. Research and Development - The company is committed to increasing R&D investments to improve biosecurity, disease prevention, and modern farming techniques[12]. - The company has established a research institute for the egg-laying chicken industry and has received approval for 2 key R&D projects in the region[136]. - Continuous investment in R&D focuses on breeding, disease prevention, nutrition, and welfare technologies, with an emphasis on applied technology development[166]. - The company is actively working on the development of new vaccines and treatments for poultry diseases to improve overall industry competitiveness[131]. - The company is exploring partnerships with upstream feed and veterinary companies to create a conducive environment for broiler chicken farming[163]. Biosecurity and Disease Prevention - The company has established a comprehensive disease prevention system, incorporating scientific farm site selection and vaccination measures to mitigate risks[54]. - The company has maintained a strong biosecurity system, with no major animal epidemics such as highly pathogenic avian influenza or Newcastle disease reported since its establishment[92]. - The company has developed a rapid detection technology system for vertically transmitted diseases, which has been implemented and promoted nationwide over the past 10 years[104]. - The company employs "sentinel chickens" for disease monitoring, which are highly sensitive to specific pathogens and provide early warning for potential outbreaks[105]. - The company has established strict quality control standards, ensuring high survival and egg production rates for its chicks[94]. Operational Efficiency and Cost Management - The company employs a two-stage full cage breeding model for commodity layer chickens, with high mechanization and automation levels in newly built facilities[53]. - The company maintains a comprehensive internal control system for procurement, focusing on cost advantages and product quality[74]. - The company reported a 5% reduction in operational costs due to improved supply chain management[9]. - The company is committed to enhancing production efficiency and product quality through standardized and automated production processes[165]. - The company has implemented a comprehensive financial and business integration system, utilizing big data for breeding management[95]. Corporate Governance and Shareholder Relations - The governance structure of the company includes a shareholders' meeting, board of directors, supervisory board, and senior management, ensuring effective operational management[177]. - The company maintains independence from its controlling shareholder, ensuring no interference in decision-making and operational activities[177]. - The company has approved a proposal to issue convertible bonds to unspecified objects, with a focus on raising funds for operational expansion[185]. - The company is committed to maintaining a stable dividend policy, reflecting its confidence in future earnings and cash flow[187]. - The company has established a plan for daily related party transactions for 2021, ensuring compliance and operational efficiency[186]. Customer Engagement and Market Strategy - The company is focused on expanding its market presence and enhancing its product offerings in the agricultural sector[192]. - User data and customer engagement strategies are being prioritized to improve service delivery and customer satisfaction[192]. - The company is exploring acquisition opportunities in the North American market to enhance its product portfolio[7]. - A new strategic partnership was announced, expected to increase market share by 15% over the next year[8]. - The company aims for a stable annual sales growth of approximately 20% while maintaining steady cash flow and increasing revenue and market share[165].

Financial Performance - The company's revenue for Q1 2022 was CNY 188,184,810.50, representing a 27.41% increase compared to CNY 147,696,606.23 in the same period last year[4]. - Net profit attributable to shareholders decreased by 21.23% to CNY 13,643,919.32 from CNY 17,322,243.33 year-on-year[4]. - Basic and diluted earnings per share decreased by 40.65% to CNY 0.073 from CNY 0.123 in the same period last year[4]. - Operating profit for the first quarter was CNY 8,482,061.70, compared to CNY 12,163,602.46 in the prior year, reflecting a decrease of 30.0%[35]. - The total comprehensive income for the first quarter was CNY 13,643,919.32, down from CNY 17,322,243.33 in the same period last year[36]. Cash Flow and Investments - The net cash flow from operating activities fell by 27.31% to CNY 22,294,117.92, down from CNY 30,670,533.72 in the previous year[4]. - The company incurred a cash outflow of CNY 124,129,965.58 from investing activities, compared to CNY 20,696,109.06 in the previous year, indicating a significant increase in investment expenditures[38]. - The company’s operating cash outflow totaled CNY 171,461,044.68, compared to CNY 132,960,645.81 in the previous year, reflecting an increase of 29.0%[38]. - Total cash inflow from financing activities was CNY 58,627,295.00, an increase from CNY 22,000,000.00 in the same period last year[38]. - The company reported cash and cash equivalents at the end of the period amounting to CNY 123,098,644.75, compared to CNY 51,019,767.82 at the end of the previous year[38]. Assets and Liabilities - Total assets increased by 5.92% to CNY 1,230,143,903.20 compared to CNY 1,161,422,423.76 at the end of the previous year[4]. - The total liabilities increased to CNY 389,559,903.89 from CNY 336,054,336.97, reflecting a rise of 15.9%[32]. - The company's equity attributable to shareholders increased to CNY 840,583,999.31 from CNY 825,368,086.79, a growth of 1.8%[33]. Operating Costs - Operating costs rose by 32.94%, attributed to increased sales volume and rising transportation costs[8]. - The total operating costs for the first quarter of 2022 were CNY 181,234,019.71, up 31.4% from CNY 137,894,180.78 in the previous year[34]. - The gross profit margin for the first quarter of 2022 was approximately 3.9%, down from the previous year's margin[34]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 18,427[10]. - The company reported a total of 240,000 shares released from restrictions for Zhu Wanqian, increasing his total holdings to 320,000 shares[13]. - The company announced that 1,000,000 shares were released from restrictions for Shi Yuxin, bringing his total to 1,100,000 shares[15]. - The company indicated that 79,960,000 shares were held by Wei Xiaoming, with an increase of 200,000 shares, totaling 80,160,000 shares[13]. - The company disclosed that 1,124,000 shares were held by Wang Xueqiang, with an increase of 50,000 shares, totaling 1,174,000 shares[13]. Stock Incentive Plans - The company has a stock incentive plan that includes various executives selling shares, with limits set for 2024 and 2025[21]. - The stock incentive plan is part of the company's broader strategy to enhance employee engagement and performance[22][23]. - The company is committed to transparency in its stock incentive program, providing detailed information on allocations and sales[22][23]. - The stock sales are scheduled to occur over a period extending to 2026, suggesting a long-term strategy for employee retention and motivation[22][23]. - The total number of shares involved in the stock incentive plans is significant, with multiple individuals participating, which may impact future share dilution[22][23].

Financial Performance - The company's revenue for Q3 2021 reached ¥179,600,214.36, representing a 23.24% increase compared to the same period last year[3] - Net profit attributable to shareholders was ¥25,115,539.91, a 39.69% increase year-on-year[3] - The net profit after deducting non-recurring gains and losses was ¥18,188,571.68, showing a slight increase of 0.76%[3] - Total operating revenue for the third quarter reached CNY 533,867,246.49, an increase of 25.1% compared to CNY 426,621,231.74 in the same period last year[20] - Operating profit amounted to CNY 64,838,301.43, up 23.1% from CNY 52,679,371.16 year-on-year[21] - Net profit attributable to the parent company was CNY 77,066,855.95, representing a growth of 53.4% compared to CNY 50,201,169.41 in the previous year[22] - Basic and diluted earnings per share increased to CNY 0.463 from CNY 0.357, reflecting a rise of 29.6%[22] Assets and Liabilities - The total assets of the company at the end of the reporting period were ¥1,113,971,720.38, up 27.39% from the end of the previous year[4] - Total assets reached CNY 1,113,971,720.38, compared to CNY 874,431,397.93 in the previous year, indicating a growth of 27.4%[20] - Total current assets as of September 30, 2021, amount to ¥315,857,931.51, a significant increase from ¥130,327,543.12 at the end of 2020[18] - Total liabilities as of September 30, 2021, are ¥293,382,358.41, an increase from ¥259,460,425.17 at the end of 2020[19] - The total liabilities rose from CNY 259,460,425.17 to CNY 282,241,073.92, indicating an increase of about 8.8%[28] - The company's non-current liabilities increased from CNY 117,944,754.87 to CNY 140,725,403.62, marking a rise of approximately 19.3%[28] Equity and Shareholder Information - The company's total equity attributable to shareholders increased by 33.44% to ¥820,589,361.97 compared to the previous year[4] - The total equity attributable to shareholders increased to CNY 820,589,361.97, up 33.5% from CNY 614,970,972.76 year-on-year[20] - The largest shareholder, Wei Xiaoming, holds 42.64% of shares, totaling 79,960,000 shares[15] - Total number of common shareholders at the end of the reporting period is 26,449[15] Cash Flow - The cash flow from operating activities for the year-to-date was ¥132,155,681.82, reflecting a 56.13% increase[3] - Cash flow from operating activities generated a net amount of CNY 132,155,681.82, up 56.1% from CNY 84,645,074.63 in the prior year[24] - The company reported a significant increase in cash flow from financing activities, totaling ¥138,541,105.29, a 144.10% increase year-on-year[11] - The cash flow from financing activities showed a net inflow of CNY 138,541,105.29, compared to CNY 56,755,740.98 in the previous period, representing a significant increase[25] Other Income and Expenses - The company received government subsidies amounting to ¥7,018,378.80 during the reporting period, contributing to the increase in other income[5] - The company reported a significant increase in other income, which rose to CNY 13,621,400.00 from CNY 1,297,501.00, marking a substantial growth[21] - Research and development expenses were CNY 17,417,064.73, slightly up from CNY 16,346,020.96, indicating continued investment in innovation[20] Cash and Cash Equivalents - The company has seen a substantial increase in its cash and cash equivalents, which rose by 381.29% to ¥209,524,624.18 compared to the end of the previous year[7] - Cash and cash equivalents increased to ¥209,524,624.18 from ¥43,533,663.01 at the end of 2020[17] - The total cash and cash equivalents at the end of the period reached CNY 209,524,624.18, an increase of CNY 165,990,961.17 compared to the previous period[25] Operational Commitments and Future Plans - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[23] - The company has ongoing rental agreements with various entities, indicating a long-term commitment to its operational infrastructure[29] Audit and Reporting - The third-quarter report was not audited, which may affect the reliability of the financial data presented[31]